Market revenue in 2023 | USD 272.7 million |
Market revenue in 2030 | USD 333.0 million |
Growth rate | 2.9% (CAGR from 2023 to 2030) |
Largest segment | Stimulants |
Fastest growing segment | Non-stimulants |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Stimulants, Non-stimulants |
Key market players worldwide | Eli Lilly and Co, Pfizer Inc, Johnson & Johnson, Lupin, Novartis AG ADR, Takeda Pharmaceutical Co Ltd, Mallinckrodt PLC Ordinary Shares - New, Vital KSK Holdings Inc, NeuroSense Therapeutics Ltd, Supernus Pharmaceuticals Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to attention deficit hyperactivity disorder market will help companies and investors design strategic landscapes.
Stimulants was the largest segment with a revenue share of 70.96% in 2023. Horizon Databook has segmented the Middle East & Africa attention deficit hyperactivity disorder market based on stimulants, non-stimulants covering the revenue growth of each sub-segment from 2018 to 2030.
Middle Eastern countries, such as Saudi Arabia, Qatar, UAE, Kuwait, and Oman, are prospering economies. Advancements in healthcare systems and the availability of generic versions of existing drugs are expected to increase the demand for drugs used to treat ADHD patients in this region. On the contrary, some countries in the African region lack adequate healthcare infrastructure.
However, in coordination with WHO or other independent organizations, governments in these countries are undertaking several initiatives for advancement of healthcare sector in the region. This is expected to help develop the market in the near future.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa attention deficit hyperactivity disorder market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa attention deficit hyperactivity disorder market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account